Proliferative Activity of Denture-Induced Fibrous Inflammatory Hyperplasia Analyzed by Proliferating Cell Nuclear Antigen Labeling Index

International Journal of Prosthodontics

Volumn 12, Issue 1, 1999, Pages 73-77

  Coelho, Cláudia Mendonça Pinto ^a,b   Zucoloto, Sérgio ^b  

^a UNIVERSITY OF RIBEIRÃO PRETO   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLINE;

ARTICLE; CELL DIVISION; DENTURE; EPITHELIUM CELL; HUMAN; HYPERPLASIA; IMMUNOHISTOCHEMISTRY; MOUTH MUCOSA; NONPARAMETRIC TEST; PATHOLOGY; RETROSPECTIVE STUDY; STOMATITIS;

CELL DIVISION; DENTURES; EPITHELIAL CELLS; HUMANS; HYPERPLASIA; IMMUNOHISTOCHEMISTRY; MOUTH MUCOSA; PROLIFERATING CELL NUCLEAR ANTIGEN; RETROSPECTIVE STUDIES; STATISTICS, NONPARAMETRIC; STOMATITIS, DENTURE;

EID: 0032603172     PISSN: 08932174     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Priddy RW. Inflammatory hyperplasias of the oral mucosa. J Can Dent Assoc 1992;58:311-321.
2. Wright SM, Scott BJJ. Prosthetic assessment in the treatment of denture hyperplasia. Br Dent J 1992;172:313-315.
3. Cutright DE. The histopathologic findings in 583 cases of epulis fissuratum. Oral Surg 1974;37:401-411.
4. Thomas GA. Denture-induced fibrous inflammatory hyperplasia (epulis fissuratum): Research aspects. Aust Prosthodont J 1993;7:49-53.
5. Keng SB, Loh HS. Clinical presentation of denture hyperplasia of oral tissues. Ann Acad Med Singapore 1989;18:537-540.
6. Hobaek A. Dental prostheses and intraoral epidermoid carcinoma. Acta Radiol 1949;32:259-275.
7. Garrafa V, Rosa LN. Neoplasias malignas das gengivas decorrentes de trauma protético. Rev Assoc Paul Cir Dent 1970; 24:197-203.
8. Whitlock RIH. Denture granuloma. Dent Pract 1972;4:1-3.
9. Boldine RL. Oral lesions caused by ill-fitting dentures. J Prosthet Dent 1969;21:580-588.
10. Swanson AE, Spouge JD. Traumatic hyperplasia of the gingiva - Alveolar fibrosis. J Can Dent Assoc 1981;47:52-56.
11. Zucoloto S, Rezende JM. Mucosal alterations in human chronic chagasic esophagopathy. Digestion 1990;47:138-142.
12. Morris GF, Matthew MB. Regulation of proliferating cell nuclear antigen during cell cycle. J Biol Chem 1989;264:13,856-13,864.
13. Tsai ST, Jin YT. Proliferating cell nuclear antigen (PCNA) expression in oral squamous cell carcinomas. J Oral Pathol Med 1995;24:313-315.
14. Million RR, Cassisi NJ. Management of Head and Neck Cancer. A Multidisciplinary Approach. Philadelphia: JB Lippincott, 1994:300-347.
15. Williams MA. Quantitative Methods in Biology. Practical Methods in Electron Microscopy. New York: North-Holland Publishers, 1981:5-84.
16. Shin DM, Voravud N, Ro JY, Lee JS, Hong WK, Hittelman WN. Sequential increases in proliferating cell nuclear antigen expression in head and neck tumorigenesis: A potential biomarker. J Natl Cancer Ins 1993;85:971-978.
17. Jin Y, Yang LJ, White FH. Preliminary assessment of the epithelial nuclear-cytoplasmatic ratio and unclear volume density in human palatal lesions. J Oral Pathol Med 1995;24:261-265.
18. World Health Organization Collaborating Centre for Oral Precancerous Lesions. Definition of leukoplakia and related lesions: An aid to studies on oral precancer. Oral Surg Oral Med Oral Pathol 1978;46:518-539.
19. Pinto Coelho CM, Zucoloto S. Hiperplasia fibro-epitelial inflamatória: Epidemiologia e atividade proliferativa celular epitelial. Rev Medicina 1998;30:558.
20. Nakao K, Yoneda K, Osaki T. Enhanced cytokine production and collagen synthesis of gingival fibroblasts from patients with denture fibromatosis. J Dent Res 1995;74:1072-1078.
21. Miller EL. Denture-induced inflammations. J Dent Assoc S Afr 1975;30:89-93.
22. Ralph JP, Stenhouse D. Denture-induced hyperplasia of the oral soft tissues. Vestibular lesions, their characteristics and treatment. Br Dent J 1972;132:68-70.
23. Watanabe Y. Oral cancer and its dental aetiological factors. Trans Int Conf Oral Surg 1970;283-293.
24. Miyachi K, Fritzler MJ, Tan EM. Autoantibody to a nuclear antigen in proliferating cells. J Immunol 1978;121:2228-2234.
25. Bravo R, Frank R, Blundell PA, Macdonald-Bravo H. Cycling/ PCNA is the auxiliary protein of DNA polymerase δ. Nature 1987;326:515-517.
26. Hall PA, Levison DA, Yu CCW, Woods AL, Kellock DB, Watkins JA. Proliferating cell nuclear antigen (PCNA) immunolocalization in paraffin sections: An index of cell proliferation with evidence of deregulated expression in some neoplasms. J Pathol 1990;162:285-294.
27. Li R, Waga S, Hannon CJ, Stillman B. Differential effects by the p21 CDK inhibitor on PCNA-dependent DNA replication and repair. Nature 1994;371:534-537.
28. Waga S, Hannon GJ, Stillman B. The p21 inhibitor of cyclin-dependent kinases controls DNA replication by interaction with PCNA. Nature 1994;369:574-578.
29. Huang WY-F, Coltera M, Schubert M, Morton T, Truelove E. Histopathologic evaluation of proliferating cell nuclear antigen (PC10) in oral epithelial hyperplasias and premalignant lesions. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1994; 78:748-754.
30. Koga Y, Kuwano H, Sugimachi K. Biologic characteristics of esophageal epithelial dysplasia assessed by proliferating cell nuclear antigen. Cancer 1996;77:237-244.
31. McCormick D, Hall PA. The complexities of proliferating cell nuclear antigen. Histopathology 1992;21:591-594.